Author

Guillaume Piton

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Anna CampalansiD· 1 shared Cécile Mathé· 1 shared Céline Lacrouts· 1 shared Didier BussoiD· 1 shared Emmanuelle BourneufiD· 1 shared Françoise PflumioiD· 1 shared Johanna NoireauxiD· 1 shared Klaudia GalantiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna CampalansORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Transplantation in neonate mouse recipients enhances umbilical cord blood CD34+ cells permissiveness to ETO2::GLIS2-driven transformation

Klaudia Galant, Vilma Barroca, Saiyirami Devanand, Didier Busso, Guillaume Piton, Nathalie Déchamps, Laurent Renou, Thomas Mercher, Stéphanie Gachet, Françoise Pflumio

This study shows that neonatal mouse recipients are more permissive than adult mice for ETO2::GLIS2-driven leukemogenesis from human cord blood CD34+ cells.

bioRxiv · Jan 13, 2026 · PreprintCancer Biology

The uptake of metallic nanoparticles in breast cancer cell lines is modulated by the hyaluronan-CD44 axis.

Marie Hullo, Cécile Mathé, Núria Fonknechten, Céline Lacrouts, Guillaume Piton, Johanna Noireaux, Sylvie Chevillard, Anna Campalans, Emmanuelle Bourneuf

The paper shows that metallic nanoparticles are taken up more by mesenchymal breast cancer cells via the HA-CD44 axis, suggesting potential for targeted therapies.

ACS Nano · Aug 4, 2025Peer-reviewedCancer Biology